Pro Share Advisors LLC Fibrogen Inc Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.89 - $2.36 $3,758 - $9,966	-4,223 Reduced 25.45%	12,368 $11,000
Q1 2024 May 08, 2024	BUY	$0.73 - $2.73 $954 - $3,570	1,308 Added 8.56%	16,591 $38,000
Q4 2023 Feb 14, 2024	SELL	$0.38 - $0.91 $1,119 - $2,681	-2,947 Reduced 16.17%	15,283 $13,000
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $72 - $260	92 Added 0.51%	18,230 $15,000
Q2 2023 Aug 10, 2023	BUY	$2.49 - $20.59 $3,276 - $27,096	1,316 Added 7.82%	18,138 $48,000
Q1 2023 May 11, 2023	SELL	$15.95 - $25.18 $35,137 - $55,471	-2,203 Reduced 11.58%	16,822 $313,000
Q4 2022 Feb 02, 2023	BUY	$13.27 - $17.73 $19,865 - $26,541	1,497 Added 8.54%	19,025 $304,000
Q3 2022 Nov 04, 2022	BUY	$11.4 - $14.6 $4,993 - $6,394	438 Added 2.56%	17,528 $229,000
Q2 2022 Aug 01, 2022	SELL	$7.94 - $12.96 $68,943 - $112,531	-8,683 Reduced 33.69%	17,090 $180,000
Q1 2022 May 10, 2022	SELL	$12.02 - $16.79 $73,213 - $102,267	-6,091 Reduced 19.12%	25,773 $310,000
Q4 2021 Feb 08, 2022	BUY	$9.93 - $15.39 $10,317 - $15,990	1,039 Added 3.37%	31,864 $449,000
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $113,374 - $296,689	-11,137 Reduced 26.54%	30,825 $315,000
Q2 2021 Aug 13, 2021	BUY	$18.57 - $35.68 $98,068 - $188,426	5,281 Added 14.4%	41,962 $1.12 Million
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $76,570 - $137,628	2,470 Added 7.22%	36,681 $1.27 Million
Q4 2020 Feb 09, 2021	BUY	$37.09 - $48.97 $292,491 - $386,177	7,886 Added 29.96%	34,211 $1.27 Million
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $20,235 - $22,750	-500 Reduced 1.86%	26,325 $1.08 Million
Q2 2020 Aug 03, 2020	BUY	$32.57 - $42.83 $286,388 - $376,604	8,793 Added 48.76%	26,825 $1.09 Million
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $311,334 - $614,117	-13,362 Reduced 42.56%	18,032 $627,000
Q4 2019 Feb 12, 2020	SELL	$34.58 - $48.06 $97,411 - $135,385	-2,817 Reduced 8.23%	31,394 $1.35 Million
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $32,246 - $42,248	-872 Reduced 2.49%	34,211 $1.27 Million
Q2 2019 Aug 13, 2019	SELL	$35.13 - $55.53 $186,821 - $295,308	-5,318 Reduced 13.16%	35,083 $1.59 Million
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $58,805 - $82,256	1,373 Added 3.52%	40,401 $2.2 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $271,751 - $430,565	-7,157 Reduced 15.5%	39,028 $1.81 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $69,643 - $83,188	1,237 Added 2.75%	46,185 $2.81 Million
Q2 2018 Aug 13, 2018	SELL	$44.9 - $64.95 $97,971 - $141,720	-2,182 Reduced 4.63%	44,948 $2.81 Million
Q1 2018 May 14, 2018	SELL	$45.35 - $61.65 $335,499 - $456,086	-7,398 Reduced 13.57%	47,130 $2.18 Million
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $175,686 - $251,698	4,188 Added 8.32%	54,528 $2.59 Million
Q3 2017 Nov 13, 2017	BUY	$33.4 - $53.9 $306,779 - $495,071	9,185 Added 22.32%	50,340 $2.71 Million
Q2 2017 Aug 11, 2017	BUY	N/A	41,155	41,155 $1.33 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account